(Q33400785)

English

Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors (English)
Pasquale W Benedetto

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit